Notes from the Field: Initial Outbreak Response Activity Following Wild Poliovirus Type 1 Detection — Malawi, February 2022

Malawi Ministry of Health; Global Polio Eradication Initiative; Elizabeth Davlantes, MD1 (View author affiliations)

View suggested citation
Article Metrics
Altmetric:
Citations:
Views:

Views equals page views plus PDF downloads

Related Materials

Since the Global Polio Eradication Initiative (GPEI) began in 1988, the number of wild poliovirus (WPV) cases has decreased by >99.99%, and five of the six World Health Organization (WHO) regions are now certified WPV-free.* WPV serotypes 2 and 3 have been declared eradicated (1), and WPV type 1 (WPV1) is currently endemic only in Pakistan and Afghanistan in the WHO’s Eastern Mediterranean Region (2,3).

The WHO African Region was certified free of indigenous WPV transmission on August 25, 2020 (4). Approximately 18 months later on February 16, 2022, a paralytic WPV1 case was confirmed in a child aged 3 years residing in Lilongwe, Malawi, in southeastern Africa, with paralysis onset November 19, 2021. The affected child had no history of travel or contact with anyone who had traveled internationally and had received only 1 of 5 doses of poliovirus vaccine recommended by the Malawi Ministry of Health through routine childhood immunization services. Genomic sequence analysis of the isolated poliovirus indicated that its closest relative was a WPV1 lineage isolated from samples taken in Sindh Province, Pakistan, in October 2019. Before this detection in Malawi, the last WPV1 case in Africa had been reported in Nigeria in 2016 (4).

Within 24 hours of virus identification, the president of Malawi declared a public health emergency and activated the country’s emergency operations center. Within 3 days of case confirmation, a team of GPEI partners had arrived in Malawi to support the Ministry of Health in strengthening acute flaccid paralysis surveillance, reeducating local clinicians and public health professionals, and organizing nationwide outbreak response supplementary immunization activities (SIAs) to reach 2.9 million children aged <5 years with bivalent oral poliovirus vaccine (bOPV, containing Sabin strain serotypes 1 and 3). The first nationwide bOPV outbreak response SIA began on March 21, 2022, and additional nationwide SIAs are planned over the coming months.

In addition, GPEI has engaged with the countries surrounding Malawi to increase their preparedness for potential cross-border spread of the virus. Until polio is eradicated worldwide, all countries must be vigilant against importation of polio and reestablishment of local transmission. GPEI teams have worked closely with the Ministries of Health in Mozambique, Tanzania, and Zambia to strengthen surveillance and support implementation of subnational bOPV SIAs in areas bordering Malawi (Figure). The coordinated campaigns began on March 24, 2022, targeting 6.4 million children aged <5 years. Subsequent nationwide SIAs are planned in these neighboring countries, as well as in Zimbabwe.

An additional case of paralytic WPV1 was detected in Tete Province, Mozambique, on April 1, 2022, with paralysis onset March 25, 2022. Existing response efforts are being modified to address this case in addition to the case in Malawi.

Corresponding author: Elizabeth Davlantes, Lyo2@cdc.gov, 404-718-4795.


1Global Immunization Division, Center for Global Health, CDC.

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.


References

  1. Bigouette JP, Wilkinson AL, Tallis G, Burns CC, Wassilak SGF, Vertefeuille JF. Progress toward polio eradication—worldwide, January 2919–June 2021. MMWR Morb Mortal Wkly Rep 2021;70:1129–35. https://doi.org/10.15585/mmwr.mm7034a1 PMID:34437527
  2. Cousins S. Polio in Afghanistan: a changing landscape. Lancet 2021;397:84–5. https://doi.org/10.1016/S0140-6736(21)00030-1 PMID:33422251
  3. Mbaeyi C, Baig S, Khan Z, et al. Progress toward poliomyelitis eradication—Pakistan, January 2020–July 2021. MMWR Morb Mortal Wkly Rep 2021;70:1359–64. https://doi.org/10.15585/mmwr.mm7039a1 PMID:34591827
  4. Fomban Leke RG, King A, Pallansch MA, et al.; Africa Regional Commission for the Certification of Poliomyelitis Eradication. Certifying the interruption of wild poliovirus transmission in the WHO African region on the turbulent journey to a polio-free world. Lancet Glob Health 2020;8:e1345–51. https://doi.org/10.1016/S2214-109X(20)30382-X PMID:32916086
Return to your place in the textFIGURE. Multicountry outbreak response supplementary immunization activity (round 1) in response to a case of wild poliovirus type 1 — Malawi, 2022
Figure is a map of Malawi and its surrounding countries (Mozambique, Tanzania, and Zambia) showing where national and subnational campaigns took place.

Suggested citation for this article: , Davlantes E. Notes from the Field: Initial Outbreak Response Activity Following Wild Poliovirus Type 1 Detection — Malawi, February 2022. MMWR Morb Mortal Wkly Rep 2022;71:776–777. DOI: http://dx.doi.org/10.15585/mmwr.mm7123a3.

MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.

Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

View Page In: PDF [179K]
Page last reviewed: June 9, 2022